The right choice can change based on history, medication interactions, side effects, budget, and availability
Their agility in adapting to emerging market trends and regulatory changes allows them to outperform larger firms in specific applications, especially in the fast-evolving landscape of weight management and diabetes treatment
Glucagon receptor agonism and energy expenditure in humans
Preclinical studies have shown that GLP-1RAs influence essential signaling pathways, including the activation of farnesoid X receptor (FXR) and liver X receptor (LXR), which are crucial in lipid metabolism and inflammation (Errafii et al., 2022)
Side effectsnausea, constipation, fatigueare common with GLP-1 therapy and require ongoing monitoring